InBioGen Co Ltd (101140) - Cash Flow Conversion Efficiency
Based on the latest financial reports, InBioGen Co Ltd (101140) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.67 Billion ≈ $-1.13 Million USD) by net assets (₩170.78 Billion ≈ $115.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See InBioGen Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
InBioGen Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how InBioGen Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check InBioGen Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
InBioGen Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InBioGen Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OTRS AG
F:TR9
|
0.155x |
|
Shanghai Guijiu Co Ltd
SHG:600696
|
0.031x |
|
Intergis
KO:129260
|
0.005x |
|
Daewon Media Co. Ltd
KQ:048910
|
-0.011x |
|
Iktinos Hellas S.A. Greek Marble Industry Technical and Touristic Company
AT:IKTIN
|
-0.030x |
|
Cypress Technology Co Ltd
TWO:3541
|
0.021x |
|
DUG Foodtech AB (publ)
ST:VUXEN
|
0.090x |
|
RMB Holdings Ltd
JSE:RMH
|
-0.038x |
Annual Cash Flow Conversion Efficiency for InBioGen Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of InBioGen Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see InBioGen Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩159.84 Billion ≈ $108.32 Million |
₩-33.13 Million ≈ $-22.45K |
0.000x | +97.07% |
| 2023-12-31 | ₩148.68 Billion ≈ $100.76 Million |
₩-1.05 Billion ≈ $-712.04K |
-0.007x | +93.59% |
| 2022-12-31 | ₩104.42 Billion ≈ $70.76 Million |
₩-11.51 Billion ≈ $-7.80 Million |
-0.110x | -177.48% |
| 2021-12-31 | ₩178.02 Billion ≈ $120.64 Million |
₩-7.07 Billion ≈ $-4.79 Million |
-0.040x | +61.49% |
| 2020-12-31 | ₩77.91 Billion ≈ $52.80 Million |
₩-8.03 Billion ≈ $-5.44 Million |
-0.103x | -77.77% |
| 2019-12-31 | ₩66.00 Billion ≈ $44.72 Million |
₩-3.83 Billion ≈ $-2.59 Million |
-0.058x | +20.27% |
| 2018-12-31 | ₩23.35 Billion ≈ $15.83 Million |
₩-1.70 Billion ≈ $-1.15 Million |
-0.073x | -93.19% |
| 2017-12-31 | ₩11.32 Billion ≈ $7.67 Million |
₩-426.44 Million ≈ $-288.99K |
-0.038x | -162.82% |
| 2016-12-31 | ₩5.75 Billion ≈ $3.90 Million |
₩344.75 Million ≈ $233.63K |
0.060x | +104.27% |
| 2015-12-31 | ₩7.80 Billion ≈ $5.29 Million |
₩-10.96 Billion ≈ $-7.43 Million |
-1.405x | -732.60% |
| 2014-12-31 | ₩4.12 Billion ≈ $2.79 Million |
₩-695.95 Million ≈ $-471.63K |
-0.169x | +45.32% |
| 2013-12-31 | ₩3.67 Billion ≈ $2.49 Million |
₩-1.13 Billion ≈ $-767.47K |
-0.309x | -- |
About InBioGen Co Ltd
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.